Merck & Co., Inc. Operating Cash Flow 2007-2026 | MRK
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is Merck & Co., Inc.'s current operating cash flow?
Merck & Co., Inc. (MRK) annual operating cash flow for 2025 was $16.47B, a 23.27% decline from 2024. Merck & Co., Inc. operating cash flow for the quarter ending March 31, 2026 was $3.92B.
What was Merck & Co., Inc.'s operating cash flow in 2024?
Merck & Co., Inc. annual operating cash flow for 2024 was $21.47B, a 65.06% increase from 2023.
What was Merck & Co., Inc.'s operating cash flow in 2023?
Merck & Co., Inc. annual operating cash flow for 2023 was $13.01B, a 31.89% decline from 2022.
What is Merck & Co., Inc.'s 5-year operating cash flow CAGR?
Merck & Co., Inc. operating cash flow grew at a compound annual growth rate (CAGR) of 9.95% from FY2020 to FY2025, going from $10.25B to $16.47B over 5 years.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+9.9%
FY2020
$10.25B
→
FY2025
$16.47B
07080910111213141516171819202122232425
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $16.47B | -23.3% | 10-K |
| FY2024 | $21.47B | +65.1% | 10-K |
| FY2023 | $13.01B | -31.9% | 10-K |
| FY2022 | $19.09B | +45.5% | 10-K |
| FY2021 | $13.12B | +28.0% | 10-K |
| FY2020 | $10.25B | -23.7% | 10-K |
| FY2019 | $13.44B | +23.1% | 10-K |
| FY2018 | $10.92B | +69.3% | 10-K |
| FY2017 | $6.45B | -37.8% | 10-K |
| FY2016 | $10.38B | -17.2% | 10-K |
| FY2015 | $12.54B | +56.9% | 10-K |
| FY2014 | $7.99B | -31.4% | 10-K |
| FY2013 | $11.65B | +16.3% | 10-K |
| FY2012 | $10.02B | -19.1% | 10-K |
| FY2011 | $12.38B | +14.4% | 10-K |
| FY2010 | $10.82B | +219.0% | 10-K |
| FY2009 | $3.39B | -48.4% | 10-K |
| FY2008 | $6.57B | -6.1% | 10-K |
| FY2007 | $7.00B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →